Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026
Go back to Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026| (NASDAQ: XAIR) | Delayed: 0.41 +0.05 (13.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $ | |||
| Open | $0.36 | 52 Week Low | $ | |||
| Day High | $0.41 | P/E | N/A | |||
| Day Low | $0.37 | EPS | $ | |||
| Volume | 312,693 | |||||

